| Literature DB >> 35040672 |
Elizabeth A Sadowski1, Isabelle Thomassin-Naggara1, Andrea Rockall1, Katherine E Maturen1, Rosemarie Forstner1, Priyanka Jha1, Stephanie Nougaret1, Evan S Siegelman1, Caroline Reinhold1.
Abstract
MRI plays an important role as a secondary test or problem-solving modality in the evaluation of adnexal lesions depicted at US. MRI has increased specificity compared with US, decreasing the number of false-positive diagnoses for malignancy and thereby avoiding unnecessary or over-extensive surgery in patients with benign lesions or borderline tumors, while women with possible malignancies can be expeditiously referred for oncologic surgical evaluation. The Ovarian-Adnexal Reporting and Data System (O-RADS) MRI Committee is an international collaborative effort formed under the direction of the American College of Radiology and includes a diverse group of experts on adnexal imaging and management who developed the O-RADS MRI risk stratification system. This scoring system assigns a probability of malignancy based on the MRI features of an adnexal lesion and provides information to facilitate optimal patient management. The widespread implementation of a codified reporting system will lead to improved interpretation agreement and standardized communication between radiologists and referring physicians. In addition, it will allow for high-quality multi-institutional collaborations-an important unmet need that has hampered the performance of high-quality research in this area in the past. This article provides guidelines on using the O-RADS MRI risk stratification system in clinical practice, as well as in the educational and research settings. © RSNA, 2022 See also the editorial by Levine in this issue.Entities:
Mesh:
Year: 2022 PMID: 35040672 PMCID: PMC8962917 DOI: 10.1148/radiol.204371
Source DB: PubMed Journal: Radiology ISSN: 0033-8419 Impact factor: 11.105